At Your Own Pace, In Your Own Space: How to Be a Hero in a Pandemic
…in her abdomen that Amy learned she had ovarian cancer. (She also had genetic testing and learned that she was positive for the BRCA gene mutation.) A project is born…
…in her abdomen that Amy learned she had ovarian cancer. (She also had genetic testing and learned that she was positive for the BRCA gene mutation.) A project is born…
…and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, BRCA1 and 2 genes). The…
…risk-reducing surgery in patients with BRCA or other high-risk mutations, and increase in opportunistic salpingectomy.” “Likely many reasons — more use of oral contraceptive pills (OCPs), less hormone replacement, better awareness,…
…that she has a mutation in the BRCA gene, which increases her risk of breast and ovarian cancers. The Alliance received many calls and requests to comment from media outlets….
…a good choice for elderly ovarian cancer patients Evaluating Olaparib for BRCA Wild-Type Platinum-Resistant Ovarian Cancer Benefit of Olaparib vs Chemo in Platinum-Sensitive Relapsed Ovarian Cancer Niraparib plus bevacizumab significantly…
…a novel based on her great grandmother who carried the BRCA gene mutation. And Morgan Gaynor raised $10,000 on a whim through a Facebook fundraiser. You can create your own Facebook fundraiser in…
…uterine, or colorectal cancer before age 50 Are of Ashkenazi or Eastern European Jewish ancestry, as BRCA mutations are more common among this group Have endometriosis Experience early menstruation What’s…
…found out that I have the BRCA1 gene mutation that put me at a greater risk of breast and ovarian cancer. While no one I knew of in my family…
…of drugs could be expand the use of PARP inhibitors beyond women with BRCA mutations. Suffice to say, it’s an exciting time with lots of potential. Immunotherapy Researchers also spent…
…diagnosed with primary peritoneal cancer in 2009, which came nearly a decade after she underwent a full hysterectomy following breast cancer and the discovery of a BRCA1 genetic mutation, Jane…
…new therapeutic target for the regimen of BRCA-mutant cancers. Research in her independent lab integrates several cutting-edge genomics and molecular biology tools to study DNA replication and repair mechanisms with…
Two studies recently released show a survival benefit for intraperitoneal IP chemotherapy Women with the BRCA1 mutation given IP chemotherapy survived three years longer than those given IV chemotherapy. Read…
Get email updates about research news, action alerts, and ways to join the fight.